Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 70% · prior close shown (market closed)
ZyVersa Therapeutics, Inc. execution reads as mixed on proprietary earnings and initiative evidence.
3 signals not yet derived from pipeline evidence
Pipeline evidence · 1d ago
ZVSA's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on ZVSA.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for ZyVersa Therapeutics, Inc. (ZVSA) — events, not interpretation.
Research & analysis only — not investment advice.
AlphaOS industries
Investment snapshot
ZVSA's AI investment thesis
Upgrade to Premium for ZVSA's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$0.31
Market cap
$2.52M
Profitable
—
Net income
—
FY Jul 17, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for ZyVersa Therapeutics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow ZyVersa Therapeutics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.